Congressional Research Service Reports - 555 Matching Results

Search Results

prev Results: 491 - 514 next
open access

Abortion Services and Military Medical Facilities

Description: The purpose of this report is to describe and discuss the provisions for providing abortion services to military personnel, their dependents and other military health care beneficiaries at military medical facilities. The report describes the history of these provisions, with particular emphasis on legislative actions. Finally, this report discusses a number of proposals to modify the Clinton Administration provisions, as well as recently enacted legislation.
Date: November 24, 2002
Creator: Burrelli, David F.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Abortion Services and Military Medical Facilities

Description: The purpose of this report is to describe and discuss the provisions for providing abortion services to military personnel, their dependents and other military health care beneficiaries at military medical facilities. The report describes the history of these provisions, with particular emphasis on legislative actions. Finally, this report discusses a number of proposals to modify the Clinton Administration provisions, as well as recently enacted legislation.
Date: April 24, 2002
Creator: Burrelli, David F.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Ecstasy: Legislative Proposals in the 107th Congress to Control MDMA

Description: Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Date: January 22, 2003
Creator: Eddy, Mark
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Ecstasy: Actions of the 107th Congress to Control MDMA

Description: Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Date: October 31, 2002
Creator: Eddy, Mark
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Ecstasy: Actions of the 107th Congress to Control MDMA

Description: Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Date: August 14, 2002
Creator: Eddy, Mark
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Ecstasy: Actions of the 107th Congress to Control MDMA

Description: Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Date: July 5, 2002
Creator: Eddy, Mark
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Cost of Prescription Drugs for the Uninsured Elderly and Legislative Approaches

Description: The purpose of this report is to explain why many of those who are least able to afford high drug costs are those who are most frequently charged the most. This report describes the basic economic theory underlying price differentiation and, in the context of the pharmaceutical market, analyzes the role and behavior of pharmacy benefit managers (PBMs), pharmaceutical manufacturers, and retail pharmacies, respectively. It also looks at a number of the criticisms that have been made of the practi… more
Date: January 16, 2001
Creator: Library of Congress. Congressional Research Service. Resources, Science, and Industry Division.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This record provides information about The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents. Congressional interests in the cost of Pharmaceuticals have focused attention on several areas where the federal government has policies and programs.
Date: January 5, 2004
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: October 9, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: September 17, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: July 15, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: June 30, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
Back to Top of Screen